A brief from the Deloitte Center for Health Solutions does a quick assessment of the status of eVisits. (Deloitte Brief) For several years the technology has existed to allow patients to have a video consultation, either through their own computers or through various kiosk-type capabilities, with a doctor or other health professional. In the kiosk model, the provider may even be able to take simple diagnostic measures, such as blood pressure, temperature, etc. Another form of eVisit is asynchronous, where the patient fills out a form online describing their symptoms or issues and a health professional reviews and responds within a short-time, usually the same day. Deloitte says that in 2014 there will be 100 million eVisits globally, a 400% growth rate from 2012. About 75 million of these visits are estimated to be in North America. There are around 600 million primary care office visits annually in the United States and Canada and half are for problems that an eVisit could be used for. The total global savings from the current level of eVisits is projected at around $5 billion and Deloitte says that the potential global market is worth $50 to $60 billion. Technological advances, concerns about provider capacity, general receptivity of consumers to online receipt of services and payer acceptance are all factors encouraging the growth of this method of receiving services. The costs are lower because the visits generally are using marginal capacity, there could be less fixed costs in building and equipment, and less staff may be needed for office management, etc. Barriers include some lingering physician resistance, regulatory issues related to scope of practice for nurse practitioners and other non-physicians, state licensing regimes and lack of acceptance by some patient groups. This is one very positive trend within health care; an example of a development that has the potential to improve access, lower the cost of care, while maintaining quality. Regulators should do everything they can to encourage the use and growth of eVisits.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
In truth, this seems like more money down a rathole. Google’s parent and other investors are putting a billion dollars into Google’s health arm, Verily. Apparently want to compete with...
September 12, 2022
It is like investors have learned nothing from the past two years. Even supposedly smart investors like Morgan Health, which is making a $20 million contribution to LetsGetChecked, which supposedly...
September 12, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace